Annual CFI
-$41.19 M
-$99.46 M-170.70%
December 31, 2023
Summary
- As of March 2, 2025, JANX annual cash flow from investing activities is -$41.19 million, with the most recent change of -$99.46 million (-170.70%) on December 31, 2023.
- During the last 3 years, JANX annual CFI has fallen by -$41.19 million (-100.00%).
- JANX annual CFI is now -170.70% below its all-time high of $58.27 million, reached on December 31, 2022.
Performance
JANX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$12.67 M
+$203.56 M+106.64%
September 30, 2024
Summary
- As of March 2, 2025, JANX quarterly cash flow from investing activities is $12.67 million, with the most recent change of +$203.56 million (+106.64%) on September 30, 2024.
- Over the past year, JANX quarterly CFI has increased by +$74.13 million (+120.62%).
- JANX quarterly CFI is now -59.21% below its all-time high of $31.07 million, reached on March 31, 2022.
Performance
JANX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$280.82 M
+$74.13 M+20.88%
September 30, 2024
Summary
- As of March 2, 2025, JANX TTM cash flow from investing activities is -$280.82 million, with the most recent change of +$74.13 million (+20.88%) on September 30, 2024.
- Over the past year, JANX TTM CFI has dropped by -$226.90 million (-420.81%).
- JANX TTM CFI is now -517.92% below its all-time high of $67.20 million, reached on September 30, 2022.
Performance
JANX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
JANX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -170.7% | +120.6% | -420.8% |
| 3 y3 years | -100.0% | +106.2% | +19.4% |
| 5 y5 years | -100.0% | +100.0% | -100.0% |
JANX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -170.7% | +87.9% | -59.2% | +106.6% | -517.9% | +20.9% |
| 5 y | 5-year | -170.7% | +87.9% | -59.2% | +106.2% | -517.9% | +20.9% |
| alltime | all time | -170.7% | +87.9% | -59.2% | +106.2% | -517.9% | +20.9% |
Janux Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $12.67 M(-106.6%) | -$280.82 M(-20.9%) |
| Jun 2024 | - | -$190.88 M(+67.8%) | -$354.95 M(+142.8%) |
| Mar 2024 | - | -$113.74 M(-1122.5%) | -$146.19 M(+254.9%) |
| Dec 2023 | -$41.19 M(-170.7%) | $11.12 M(-118.1%) | -$41.19 M(-23.6%) |
| Sep 2023 | - | -$61.45 M(-443.8%) | -$53.92 M(-297.6%) |
| Jun 2023 | - | $17.87 M(-304.5%) | $27.29 M(+47.9%) |
| Mar 2023 | - | -$8.74 M(+444.9%) | $18.46 M(-68.3%) |
| Dec 2022 | $58.27 M | -$1.60 M(-108.1%) | $58.27 M(-13.3%) |
| Sep 2022 | - | $19.76 M(+118.6%) | $67.20 M(-142.5%) |
| Jun 2022 | - | $9.04 M(-70.9%) | -$158.11 M(-49.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $31.07 M(+324.1%) | -$309.74 M(-9.2%) |
| Dec 2021 | -$340.96 M(<-9900.0%) | $7.33 M(-103.6%) | -$340.96 M(-2.1%) |
| Sep 2021 | - | -$205.54 M(+44.1%) | -$348.29 M(+144.0%) |
| Jun 2021 | - | -$142.60 M(>+9900.0%) | -$142.75 M(>+9900.0%) |
| Mar 2021 | - | -$153.00 K(<-9900.0%) | -$153.00 K(<-9900.0%) |
| Dec 2020 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2020 | - | $0.00 | $0.00 |
| Dec 2019 | $0.00 | - | - |
FAQ
- What is Janux Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Janux Therapeutics?
- What is Janux Therapeutics annual CFI year-on-year change?
- What is Janux Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Janux Therapeutics?
- What is Janux Therapeutics quarterly CFI year-on-year change?
- What is Janux Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Janux Therapeutics?
- What is Janux Therapeutics TTM CFI year-on-year change?
What is Janux Therapeutics annual cash flow from investing activities?
The current annual CFI of JANX is -$41.19 M
What is the all time high annual CFI for Janux Therapeutics?
Janux Therapeutics all-time high annual cash flow from investing activities is $58.27 M
What is Janux Therapeutics annual CFI year-on-year change?
Over the past year, JANX annual cash flow from investing activities has changed by -$99.46 M (-170.70%)
What is Janux Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of JANX is $12.67 M
What is the all time high quarterly CFI for Janux Therapeutics?
Janux Therapeutics all-time high quarterly cash flow from investing activities is $31.07 M
What is Janux Therapeutics quarterly CFI year-on-year change?
Over the past year, JANX quarterly cash flow from investing activities has changed by +$74.13 M (+120.62%)
What is Janux Therapeutics TTM cash flow from investing activities?
The current TTM CFI of JANX is -$280.82 M
What is the all time high TTM CFI for Janux Therapeutics?
Janux Therapeutics all-time high TTM cash flow from investing activities is $67.20 M
What is Janux Therapeutics TTM CFI year-on-year change?
Over the past year, JANX TTM cash flow from investing activities has changed by -$226.90 M (-420.81%)